Pathological complete response and accelerated drug approval in early breast cancer

N Engl J Med. 2012 Jun 28;366(26):2438-41. doi: 10.1056/NEJMp1205737. Epub 2012 May 30.
No abstract available

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant*
  • Drug Approval*
  • Female
  • Humans
  • Time Factors
  • United States
  • United States Food and Drug Administration